193 related articles for article (PubMed ID: 24554667)
1. Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.
Hu Z; Wang J; Wan Y; Zhu L; Ren X; Qiu S; Ren Y; Yuan S; Ding X; Chen J; Qiu C; Sun J; Zhang X; Xiang J; Qiu C; Xu J
J Virol; 2014 May; 88(10):5356-68. PubMed ID: 24554667
[TBL] [Abstract][Full Text] [Related]
2. Immune Signature of Enhanced Functional Avidity CD8
Hu Z; Zhu L; Wang J; Wan Y; Yuan S; Chen J; Ding X; Qiu C; Zhang X; Qiu C; Xu J
Sci Rep; 2017 Feb; 7():41558. PubMed ID: 28155878
[TBL] [Abstract][Full Text] [Related]
3. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus.
Zhao Y; De Trez C; Flynn R; Ware CF; Croft M; Salek-Ardakani S
J Immunol; 2009 May; 182(10):6278-86. PubMed ID: 19414781
[TBL] [Abstract][Full Text] [Related]
4. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.
Seneschal J; Jiang X; Kupper TS
J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
[TBL] [Abstract][Full Text] [Related]
6. A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection.
Quigley M; Martinez J; Huang X; Yang Y
Blood; 2009 Mar; 113(10):2256-64. PubMed ID: 18948575
[TBL] [Abstract][Full Text] [Related]
7. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
8. Surprisingly Effective Priming of CD8
Croft S; Wong YC; Smith SA; Flesch IEA; Tscharke DC
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759313
[TBL] [Abstract][Full Text] [Related]
9. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.
Green S; Ennis FA; Mathew A
Vaccine; 2011 Feb; 29(8):1666-76. PubMed ID: 21195803
[TBL] [Abstract][Full Text] [Related]
10. Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.
Belyakov IM; Ahlers JD; Nabel GJ; Moss B; Berzofsky JA
Virology; 2008 Nov; 381(1):106-15. PubMed ID: 18793787
[TBL] [Abstract][Full Text] [Related]
11. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
12. Immunodomination during peripheral vaccinia virus infection.
Lin LC; Flesch IE; Tscharke DC
PLoS Pathog; 2013; 9(4):e1003329. PubMed ID: 23633956
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides.
Wang Y; Flesch IE; Tscharke DC
J Virol; 2009 Sep; 83(17):9008-12. PubMed ID: 19535449
[TBL] [Abstract][Full Text] [Related]
14. TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
Jayakumar A; Castilho TM; Park E; Goldsmith-Pestana K; Blackwell JM; McMahon-Pratt D
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1204. PubMed ID: 21695103
[TBL] [Abstract][Full Text] [Related]
15. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.
Haglund K; Leiner I; Kerksiek K; Buonocore L; Pamer E; Rose JK
J Virol; 2002 Aug; 76(15):7506-17. PubMed ID: 12097563
[TBL] [Abstract][Full Text] [Related]
16. The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells.
Hovav AH; Panas MW; Osuna CE; Cayabyab MJ; Autissier P; Letvin NL
J Virol; 2007 Dec; 81(23):12793-802. PubMed ID: 17881444
[TBL] [Abstract][Full Text] [Related]
17. MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.
Davies ML; Sei JJ; Siciliano NA; Xu RH; Roscoe F; Sigal LJ; Eisenlohr LC; Norbury CC
J Virol; 2014 Mar; 88(6):3557-67. PubMed ID: 24403581
[TBL] [Abstract][Full Text] [Related]
18. Intradermal immune response after infection with Vaccinia virus.
Jacobs N; Chen RA; Gubser C; Najarro P; Smith GL
J Gen Virol; 2006 May; 87(Pt 5):1157-1161. PubMed ID: 16603516
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
J Virol; 2019 May; 93(10):. PubMed ID: 30814284
[TBL] [Abstract][Full Text] [Related]
20. OX40 drives protective vaccinia virus-specific CD8 T cells.
Salek-Ardakani S; Moutaftsi M; Crotty S; Sette A; Croft M
J Immunol; 2008 Dec; 181(11):7969-76. PubMed ID: 19017988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]